MCs were treated with 100 nM PTHrP (1–34) for indicated time. (A) mRNA level of TGF-β1 was assessed by RT-PCR (*P<0.05 vs control, n=4). (B) Protein expression of TGF-β1 and TβRII was detected by western blot, with β-actin used as loading control (*P<0.05 vs control, n=3). (C) Protein level of fibronectin was assessed by western blot (*P<0.05 vs control, n=4). (D) MCs were pretreated with TGFβ receptor inhibitor SB431542 before PTHrP (1–34) incubation for 24 or 48 h. Protein level of fibronectin was assessed by western blot (*P<0.05 vs control, n=3).